06951649 is referenced by 4 patents and cites 7 patents.

The present invention relates to a method for formulating a vaccine composition which comprises an anti-influenza vaccine, wherein the improvement of the vaccine composition is that the vaccine includes, as an additive, neuraminidase (NA). The base anti-influenza vaccine can be any commercially available anti-influenza vaccine. The improved composition can include and be administered with an adjuvant. The improved vaccine composition provides protection in a host, animal or human, against influenza infection, including viral replication and systemic infection.

Title
Methods of making neuraminidase-supplemented compositions
Application Number
10/264813
Publication Number
6951649 (B2)
Application Date
October 4, 2002
Publication Date
October 4, 2005
Inventor
Franklin Volvovitz
Woodridge
CT, US
Craig S Hackett
Wallingford
CT, US
Andrie I Voznesensky
West Hartford
CT, US
Bethanie E Wilkinson
Higganum
CT, US
Bert E Johansson
Armonk
NY, US
Edwin D Kilbourne
Madison
CT, US
James T Matthews
Allamuchy
NJ, US
Gail Eugene Smith
Wallingford
CT, US
Agent
Angela M Collison
Thomas J Kowalski
Frommer Lawrence & Haug
Assignee
Protein Sciences Corporation
CT, US
IPC
A61K 039/295
A61K 039/145
View Original Source